
ACT Brief: Community Research Financing Gaps, Neuroscience Endpoint Data, and Teva’s Biosimilar Deal
4.11.2026
0:00
1:57
In today’s ACT Brief, we examine why community research needs lasting financing and infrastructure, how electronic outcome tools can strengthen neuroscience endpoints, and how Teva is licensing two biosimilars from Samsung Bioepis.
Weitere Episoden von „Applied Clinical Trials“



Verpasse keine Episode von “Applied Clinical Trials” und abonniere ihn in der kostenlosen GetPodcast App.








